172 results on '"Paparo, Sabrina Rosaria"'
Search Results
2. Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series
3. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
4. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy
5. New insight in endocrine-related adverse events associated to immune checkpoint blockade
6. Endocrine disruptors and thyroid autoimmunity
7. Novel therapies for thyroid autoimmune diseases: An update
8. The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases
9. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy
10. Thyroid Autoimmunity and SARS-CoV-2 Infection
11. Myo-inositol in autoimmune thyroiditis, and hypothyroidism
12. The protective effect of myo-inositol on human thyrocytes
13. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer
14. Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review.
15. Thyroid Metastasis from Primary Breast Cancer
16. Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis
17. Teprotumumab for the treatment of thyroid eye disease
18. Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies
19. Molecular features of aggressive thyroid cancer
20. Corticosteroids and mycophenolic acid have a synergistic effect on chemokines secretion in orbital cells from patients with graves' ophthalmopathy
21. The effect on serum tsh levels in patients in treatment with proton pump inhibitors after the switch from oral L-T4 tablet to a liquid L-T4 formulation
22. TSH levels assessment in hypothyroid patients treated with liquid or tablet l-thyroxine
23. PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
24. ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
25. Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
26. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
27. Myoinositol in Autoimmune Thyroiditis
28. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
29. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
30. Autoimmune thyroiditis and hypothyroidism: a personalized medical approach
31. Molecular targets of tyrosine kinase inhibitors in thyroid cancer
32. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin
33. Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture.
34. Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
35. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
36. Precision Medicine in Graves’ Disease and Ophthalmopathy
37. Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
38. Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer
39. COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
40. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
41. The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
42. Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
43. Serum TSH Levels Normalisation in Patients Affected by Autoimmune Atrophic Gastritis, After the Switch From Oral L-T4 in Tablet Form to L-T4 in Liquid Formulation
44. Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
45. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
46. L-T4 Therapy in Enteric Malabsorptive Disorders
47. THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors
48. Thyroid autoimmune disorders and cancer
49. Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies
50. Novel treatments for anaplastic thyroid carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.